Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generation Bio
Biotech
Generation Bio jettisons 90% of employees, including R&D org
Generation Bio is shedding 90% of its workforce after the biotech acknowledged it’s unlikely to find cash to take its lipid nanoparticle tech further.
James Waldron
Aug 13, 2025 5:00am
Generation Bio eliminates 40% of staff, including C-suite execs
Nov 29, 2023 8:58am
Moderna pays Generation Bio $76M in lipid nanoparticle collab
Mar 23, 2023 10:58am
Generation Bio shares halved on hemophilia gene therapy setback
Dec 14, 2021 2:30pm
Next-gen gene therapies for rare diseases forge ahead
Dec 14, 2020 5:28am
Cell and gene therapy in the time of COVID-19: report
Aug 6, 2020 9:00am
